EMAIL THIS PAGE TO A FRIEND

Oncotarget

Blockade of telomerase reverse transcriptase enhances chemosensitivity in head and neck cancers through inhibition of AKT/ERK signaling pathways.


PMID 26497550

Abstract

We're sorry this abstract is currently not available.